Sara Bartel

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Posttraumatic stress disorder (PTSD) and eating disorders (EDs) frequently co-occur, with PTSD potentially worsening ED treatment outcomes. Integrated and concurrent interventions that treat both conditions together have been recommended, but no best practices exist. This case series of nine patients provides preliminary data on Written Exposure Therapy (WET), a brief, low-resource PTSD intervention, delivered concurrently with inpatient or day hospital ED treatment.

1 INTRODUCTION There has been increasing discourse about glucagon-like peptide-1 receptor agonists (GLP-1As), such as semaglutide (Han et al., 2023). GLP-1As stabilize blood glucose by stimulating insulin secretion and suppressing glucagon production in the body (Food and Drug Administration [FDA], 2022). They also slow gastric emptying and affect appetite-regulating neural pathways, which can increase satiety and reduce food intake in some individuals (Ard et al., 2021).